Purchase Order 75N95024P00604
Award Date 9/16/24
Potential Completion Date 10/15/24
Potential Value $240K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Durham, NC 27707, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute on Drug Abuse awarded a $101,000 firm fixed-price purchase order to Chemogenics Biopharma, LLC on September 16, 2025, for synthesis and bioanalytical analysis services supporting the National Center for Advancing Translational Sciences (NCATS) Early Translational Branch Chemistry Program. The contract, which extends through July 15, 2026, is performable in Durham, North Carolina. This procurement does not utilize a small business set-aside designation. The work involves...
- The National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH) awarded a $30,035 firm fixed price purchase order to Medchemexpress LLC of Princeton, New Jersey for the synthesis of synthetic compounds to support NCATS. Under the terms of the award, Medchemexpress will provide synthetic compound synthesis services to NCATS by November 11, 2022. No set-aside provisions were applied to this procurement. As the lead institute for NIH's translational...
- The National Institutes of Health's National Center for Advancing Translational Sciences awarded a $99,000 firm fixed price purchase order to Targetmol Chemicals Inc. to synthesize analogs of repsox and intermediates from two ongoing medicinal chemistry projects. Over a six-month period after receipt of order, Targetmol will synthesize the requested compounds and deliver milligram to gram quantities to NCATS along with electronic progress reports, analytical data including LCMS and 1H NMR, and...
- This is a $249,500 firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse to Chemogenics Biopharma, LLC, a small business. The contract is for synthesis and bioanalytical analysis support services related to the therapeutic areas of the microbiome, neurodegeneration, and addiction. The services will augment existing medicinal chemistry campaigns within the National Center for Advancing Translational...
- This is a $24,900.00 firm fixed price purchase order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse to Chemogenics Biopharma, LLC, a for-profit limited liability company and sole proprietorship, on July 23, 2019. The contract has a completion date of September 30, 2019 and does not have a set-aside designation. Chemogenics Biopharma, LLC is a leading company in preclinical drug discovery and has been awarded several...
- The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $24,512.25 firm fixed-price purchase order to Life Technologies Corporation of Carlsbad, California. As the prime contractor, Life Technologies will provide products or services to NIH NCATS between August 31 and October 1, 2023. The award is not associated with a multiple award contract vehicle. No subcontractors or set aside designations were indicated....
- This is a $447,635.80 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. government. The contract is for the "SMALL MOLECULES FOR NCATS PHARMACOLOGICALLY ACTIVE CHEMICAL TOOLBOX (NPACT)" program and was awarded to Analyticon Discovery, LLC, a for-profit foreign-owned organization. The contract does not have a set-aside designation and has an ultimate completion date of January 31, 2016. NCATS is...
- The National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services, has awarded a $1,785,000.00 firm fixed price purchase order contract to X-Chem, Inc., a for-profit drug discovery company. The 8-month contract, which runs from May 2023 through January 2024, does not have a set-aside designation. Based on X-Chem's prior work as a subcontractor on federal grants focused on early-stage drug discovery research, the contract likely...
- The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a firm-fixed price purchase order to Fisher Scientific Company L.L.C. valued at $24,010.95 to provide multiple formulation-related laboratory tools and equipment. The solicitation requested brand name or equal laboratory items to support the agency's research and development efforts. Performance will take place in Potomac, Maryland over a three-month period...
- This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to Cellmosaic, Inc., a small disadvantaged business, for the synthesis and delivery of 100g of the lead NNMT inhibitor compound '960 over a 12-month period. The total contract value is $45,000.00. The award was made through a non-competitive, commercial item acquisition under FAR Parts 13 and 12, as Cellmosaic was...